02157.HK
Lepu Biopharma Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 4.06
+3.44%Margins
Gross margin
79.1%
EBITDA margin
11.6%
EBIT margin
6.9%
Net margin
24.9%
FCF margin
-8.5%
17.2%
Return on equity
7.7%
Return on assets
2.6%
Return on invested capital
0.31x
Asset turnover
-HKD 45.1M
Cash from operations
HKD 0.53
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026